These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25693305)

  • 1. Evidence-based management of Kawasaki disease in the emergency department.
    Seaton KK; Kharbanda A
    Pediatr Emerg Med Pract; 2015 Jan; 12(1):1-20; quiz 21. PubMed ID: 25693305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of kawasaki disease.
    Saguil A; Fargo M; Grogan S
    Am Fam Physician; 2015 Mar; 91(6):365-71. PubMed ID: 25822554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
    Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Complexities of the Diagnosis and Management of Kawasaki Disease.
    Rowley AH
    Infect Dis Clin North Am; 2015 Sep; 29(3):525-37. PubMed ID: 26154665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease.
    Newburger JW; Fulton DR
    Curr Opin Pediatr; 2004 Oct; 16(5):508-14. PubMed ID: 15367843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease.
    Scuccimarri R
    Pediatr Clin North Am; 2012 Apr; 59(2):425-45. PubMed ID: 22560578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki Disease.
    Newburger JW; Takahashi M; Burns JC
    J Am Coll Cardiol; 2016 Apr; 67(14):1738-49. PubMed ID: 27056781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of children with Kawasaki disease.
    Gidding SS; Shulman ST
    Heart Dis Stroke; 1994; 3(4):210-5. PubMed ID: 7921666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease. The mystery continues.
    Bradley DJ; Glodé MP
    West J Med; 1998 Jan; 168(1):23-9. PubMed ID: 9448484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki syndrome.
    Wortmann DW
    Semin Dermatol; 1992 Mar; 11(1):37-47. PubMed ID: 1550715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ; Saulsbury FT
    Clin Pediatr (Phila); 2007 May; 46(4):345-8. PubMed ID: 17475994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease: summary of the American Heart Association guidelines.
    Freeman AF; Shulman ST
    Am Fam Physician; 2006 Oct; 74(7):1141-8. PubMed ID: 17039750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.